NCT06537453 UPTAKE - Virtual Care: Virtual Home Hospital With Remote Monitoring to Reduce Acute Care Hospitalization
| NCT ID | NCT06537453 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Calgary |
| Condition | Acute Kidney Injury |
| Study Type | INTERVENTIONAL |
| Enrollment | 354 participants |
| Start Date | 2024-08-10 |
| Primary Completion | 2026-08-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 354 participants in total. It began in 2024-08-10 with a primary completion date of 2026-08-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Method: Randomized Controlled Trial Study Duration: 3 Years Study Centre(s) University of Calgary and University of Alberta Objectives: To fill care gaps by implementing strategies to reduce length of hospital stay, readmission rates, and improve long-term outcomes after Acute Kidney Injury (AKI). Number of Participants: Three Hundred and fifty four (n=354) Diagnosis and Main Inclusion Criteria: Hospitalized adults with AKI at high risk of hospital readmission or death Study Intervention: Multi-component Digital Health Solutions, including: 1. Computerized Clinical Decision Support (CDS) and 2. Virtual Care Delivered through Hospital at Home (VC) Duration of administration: Determined by the Patient's clinical team Reference therapy: Usual Care Statistical Analyses: Descriptive Analysis, Regression
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years old. * AKI identified in hospital using Kidney Disease Improving Global Outcomes (KDIGO) criteria17. * Hospitalization \> 48 hours. * LACE (L= Length patient Stay in the hospital, A= Acuity of Admission of patient in the hospital, C= Comorbidity and E= Emergency Visit.) Score 12 or higher. * Meets all inclusion criteria of Virtual Home Hospital programs of Calgary and Edmonton zones. Exclusion Criteria: * Non-Alberta residents. * Resides outside the catchment areas for the Calgary and Edmonton Virtual Home Hospital programs. * C1 or C2 goals of care. * Hospitalization \> 30 days. * Will be discharged to long-term care. * Kidney failure receiving dialysis. * Already admitted in Virtual Home Hospital Program
Contact & Investigator
Matthew James, MD
PRINCIPAL INVESTIGATOR
University of Calgary
Frequently Asked Questions
Who can join the NCT06537453 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Kidney Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06537453 currently recruiting?
Yes, NCT06537453 is actively recruiting participants. Contact the research team at cccr@ucalgary.ca for enrollment information.
Where is the NCT06537453 trial being conducted?
This trial is being conducted at Calgary, Canada, Edmonton, Canada.
Who is sponsoring the NCT06537453 clinical trial?
NCT06537453 is sponsored by University of Calgary. The principal investigator is Matthew James, MD at University of Calgary. The trial plans to enroll 354 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.